{"transactions":[{"id":2880992,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143106,"kind":"person","name":"Obermayr Franz","position":1,"cik":"0001843571","reported_name":"Obermayr Franz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T02:50:48.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years."}],"balance_after":30000,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-21-011844","document":"tm215262-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011844/tm215262-2_4seq1.xml","form_type":"4"}}]}